Basic Information
Basic information for CCDC26-269-14aa
Peptide Name CCDC26-269-14aa
Genome Position chr8:129216662-129216703[-]
Species Human
Peptide Sequence MPFPNLFLNCLKLT
Peptide Length 14
Unique No (CCDC26-202-14aa,CCDC26-214-14aa,CCDC26-218-14aa,CCDC26-219-14aa,CCDC26-220-14aa,CCDC26-221-14aa,CCDC26-222-14aa,CCDC26-224-14aa,CCDC26-225-14aa,CCDC26-226-14aa,CCDC26-230-14aa,CCDC26-232-14aa,CCDC26-234-14aa,CCDC26-238-14aa,CCDC26-240-14aa,CCDC26-241-14aa,CCDC26-242-14aa,CCDC26-248-14aa,CCDC26-249-14aa,CCDC26-250-14aa,CCDC26-251-14aa,CCDC26-258-14aa,CCDC26-259-14aa,CCDC26-260-14aa,CCDC26-261-14aa,CCDC26-265-14aa,CCDC26-266-14aa,CCDC26-267-14aa,CCDC26-271-14aa,CCDC26-272-14aa,CCDC26-274-14aa,CCDC26-276-14aa,CCDC26-278-14aa)
Grand Average of Hydropathicity 0.7429
Relative Molecular Mass 1885.28
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000229140;CCDC26
Transcript ID/Name ENST00000669617;CCDC26-269
Transcript Length 1425
Coding Ability 0.3284
DNA Sequence Corresponding to Peptide ATGCCATTTCCTAATCTTTTCTTGAATTGCCTGAAACTCACC
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :